Home Compare GSK.L vs ZTS
Stock Comparison · Structural lead, mixed market

GSK vs Zoetis: Which Stock Looks Stronger in 2026?

GSK holds the cleaner structural position, with the lead spread across growth and stability. Zoetis still has the edge on profitability, which keeps the comparison from looking entirely one-sided. On the market side, GSK is in better shape — its trend is intact while Zoetis's trend has broken down. That puts structure and market broadly in agreement — GSK's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both growth and stability materially support the lead.

Trajectory Similarity
0.74
Similar
Peer-set rank: #4
within GSK plc's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The clearest structural overlap shows up in recent revenue growth and capital structure.

Similarity drivers
recent revenue growthcapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
GSK.L
GSK plc
65
Peer-Score
Signal qualityHigh
vs
ZTS
Zoetis Inc.
59
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: GSK.L vs ZTS Profitability 46 85 Stability 69 23 Valuation 80 82 Growth 71 20 GSK.L ZTS
Gap Ranking
#1 Growth +51
#2 Stability +46
#3 Profitability +39
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GSK.L and ZTS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GSK.LZTS Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
GSK plc ranks near the top of the group on growth; Zoetis Inc. sits in the weaker half.
Stability
On stability, the gap still runs the same way: GSK plc sits near the top of the group, while Zoetis Inc. remains in the weaker half.
Growth — Dominant Gap
GSK.L
71
ZTS
20
Gap+51in favour of GSK.L

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Profitability still favours Zoetis, with a 15.8-point operating margin advantage keeping the comparison from looking fully resolved.

What this means for the comparison

The lead is built on both growth and stability — though profitability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the GSK.L vs ZTS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how GSK.L and ZTS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.